NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.
Cincinnati, Ohio – February 24, 2020 – Protech Home Medical Corp. (the “Company”) (TSXV: PTQ), a healthcare services company with operations in the U.S., is pleased to announce it has been named to the 2020 TSX Venture 50TM. This is the TSX Venture Exchange’s annual ranking of top performing companies on the TSX Venture Exchange. Each of the top 10 companies in each of five major industry sectors have been identified as leaders in creating shareholder value based on three key criteria: share price appreciation, market capitalization growth and trading volume. There are over of 1,600 companies listed on the TSX Venture Exchange.
“2019 was a dynamic year for us, we strengthened our core business, developed more sales personnel, established strong scalable business processes, and completed two accretive acquisitions,” commented Greg Crawford, Chairman and Chief Executive Officer of the Company. “We are honored to be recognized and named to the TSX Venture 50 which serves as confirmation that our three-pronged strategy is positioning our company and shareholders for success. With acceleration of growth through our existing customer base and new acquisition opportunities, as well as a laser focus on sustainable margin expansion , our outlook for 2020 and beyond is extremely positive and we are excited to share all of our developments with our current and future shareholders. I’d like to thank the entire Protech team for their tireless efforts and its stakeholders for all their continued support.”